Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlos Msaouel

Showing results (131-140 of 246) with videos related to

Pageof 25
Sort By:
Current Oncology (Toronto, Ont.)|October 27, 2023
Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular TestingJ Bryan Iorgulescu, Leah K Shaw, Asif Rashid, et al.
BJU International|July 9, 2023
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trialsDaniele Robesti, Luigi Nocera, Federico Belladelli, et al.
Heart & Lung : the Journal of Critical Care|August 30, 2014
Thrombocytopenia is an independent predictor of mortality in pulmonary hypertensionMohammad Khalid Mojadidi, David Goodman-Meza, Parham Eshtehardi, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysisMohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi, et al.
American Journal of Hematology|July 6, 2013
Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemiaAnthony P Lam, Krishna Gundabolu, Ashwin Sridharan, et al.
The Oncologist|June 2, 2024
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trialsAlexander D Sherry, Pavlos Msaouel, Ramez Kouzy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2009
Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporterPavlos Msaouel, Ianko D Iankov, Cory Allen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2018
Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysisMatthew T Campbell, Mehmet A Bilen, Amishi Y Shah, et al.
JCO Precision Oncology|September 30, 2024
Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in OncologyAlexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
The Oncologist|March 13, 2024
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell CarcinomaAndrew C Johns, Matthew T Campbell, Mamie Gao, et al.
Pageof 25

Showing results (131-140 of 246) with videos related to

Sort By:
Pageof 25
Current Oncology (Toronto, Ont.)|October 27, 2023
Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular TestingJ Bryan Iorgulescu, Leah K Shaw, Asif Rashid, et al.
BJU International|July 9, 2023
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trialsDaniele Robesti, Luigi Nocera, Federico Belladelli, et al.
Heart & Lung : the Journal of Critical Care|August 30, 2014
Thrombocytopenia is an independent predictor of mortality in pulmonary hypertensionMohammad Khalid Mojadidi, David Goodman-Meza, Parham Eshtehardi, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysisMohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi, et al.
American Journal of Hematology|July 6, 2013
Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemiaAnthony P Lam, Krishna Gundabolu, Ashwin Sridharan, et al.
The Oncologist|June 2, 2024
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trialsAlexander D Sherry, Pavlos Msaouel, Ramez Kouzy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2009
Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporterPavlos Msaouel, Ianko D Iankov, Cory Allen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2018
Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysisMatthew T Campbell, Mehmet A Bilen, Amishi Y Shah, et al.
JCO Precision Oncology|September 30, 2024
Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in OncologyAlexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
The Oncologist|March 13, 2024
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell CarcinomaAndrew C Johns, Matthew T Campbell, Mamie Gao, et al.
Pageof 25